Defective lipid metabolism promotes hyperlipidemia and ectopic lipid accumulation [60], and lipid overload in non-adipose tissue is associated with impairment of insulin signaling pathways and subsequent reduction in muscle glucose uptake, thereby resulting in muscle IR [61–63]. The gene discussed is INS; the disease is hyperlipidemia.